Genomic Unity® Case Study

Variantyx. See more from the very first test.

Overview

Patient: 


4-year-old male

Clinical presentation:


Hearing impairment, enlarged kidney, nephritis, proteinuria, autism, speech delay, clumsiness, toe walking

Testing strategy:

Variantyx whole genome testing

Key finding:

Pathogenic inversion disrupting the COL4A5 gene

Clinical outcome:

Diagnosis established and family testing enabled

Why Genomic Unity® was the right choice

The patient presented with suspicion for Alport syndrome and a history of affected males who had progressed to end-stage renal disease in the maternal lineage. However, prior targeted testing of a male relative and the patient’s mother had both been negative for Alport syndrome. As had targeted testing of the patient.

Genomic Unity® was selected over exome as a comprehensive test because it delivers the most comprehensive genomic insight from the start while:

  • Reducing time to diagnosis
  • Avoiding unnecessary testing
  • Supporting the highest standard of patient care

Diagnostic finding: Alport syndrome

Variantyx Genomic Unity® testing identified a pathogenic, maternally inherited 4.14 Mb inversion in the Xq22.2 to Xq22.3 region. Spanning multiple genes, the 3′-breakpoint of the inversion falls within an intron of the COL4A5 gene. Disrupting exons 1-18,  the inversion is expected to result in loss of COL4A5 protein function.

IGV view of left and right inversion breakpoints

Uniform data from WGS clearly identifies both the intergenic 5′-breakpoint (left) and the intronic 3′-breakpoint (right).

Impact on clinical care

Enabled targeted follow-on screening of at-risk family members.

Variant spotlight

Detection challenges

Exome and panel tests focus on coding regions only, ignoring intergenic and intronic sequences. This leads to critical coverage gaps that make it impossible to detect inversion breakpoints within these regions. Breakpoint detection is the only way to identify disruptive, pathogenic inversions.

Why Genomic Unity®

  • Sequences and analyzes both coding and non-coding regions, enabling breakpoint detection regardless of location
  • Detects additional variant types that may occur in trans

Additional similar cases

Genomic Unity® – DMD inversion provides genetic diagnosis, enabling access to treatment options

Genomic Unity® – Inversion explains developmental delay and physical anomalies

The choice is in your hands. Choose Variantyx.

Talk with a Clinical Specialist